MOTS-C in Costa Rica: The Mitochondrial Peptide for Energy, Metabolism & Longevity
MOTS-C is one of the most scientifically fascinating peptides to emerge from longevity research in recent years — and one of the few compounds that originates not from conventional protein synthesis pathways, but from the mitochondrial genome itself.
Discovered in 2015 by researchers at the University of Southern California, MOTS-C has rapidly become a subject of intense interest in the fields of metabolic medicine, exercise physiology, and longevity science for its unique ability to regulate cellular energy metabolism and support healthy aging at the mitochondrial level.
At Rejuvilife in Escazú, Costa Rica, Dr. Alan Inman follows the evolving science around mitochondrial peptides closely as part of his commitment to staying at the forefront of regenerative and longevity medicine.
What Is MOTS-C?
MOTS-C — Mitochondrial Open Reading Frame of the Twelve S rRNA type-c — is a naturally occurring peptide encoded by the mitochondrial genome. Unlike most peptides, which are encoded by nuclear DNA, MOTS-C is produced within the mitochondria themselves — the energy-producing structures present in virtually every cell of the human body.
This mitochondrial origin is significant. MOTS-C functions as a mitochondrial-derived peptide (MDP) — a newly recognized class of signaling molecules that communicate between mitochondria and other cellular and systemic systems, regulating metabolism, stress responses, and aging processes.
MOTS-C levels naturally decline with age, and this decline is associated with reduced metabolic efficiency, increased insulin resistance, and accelerated biological aging — making it a compelling target for longevity-focused interventions.
What Does the Research Suggest?
Research on MOTS-C has produced several findings of significant interest to metabolic medicine and longevity science:
Metabolic regulation and insulin sensitivity
MOTS-C has demonstrated the ability to regulate glucose metabolism and improve insulin sensitivity in preclinical studies. Research published in Cell Metabolism showed that MOTS-C administration in animal models prevented diet-induced obesity and insulin resistance — effects that were associated with improved mitochondrial function and cellular energy metabolism.
Exercise mimetic effects
One of the most striking findings in MOTS-C research is its ability to mimic some of the metabolic effects of exercise at the cellular level. Studies suggest MOTS-C activates AMPK — a key cellular energy sensor and metabolic regulator — producing effects on glucose uptake, fat oxidation, and metabolic flexibility that overlap with those induced by physical exercise.
This has led to MOTS-C being discussed as an "exercise mimetic" — a compound that may activate some of the molecular pathways through which exercise produces its metabolic benefits.
Longevity and healthy aging
Research in animal models has shown that MOTS-C administration is associated with extended lifespan and improved healthspan — the period of life characterized by good health and functional capacity. These effects appear to be mediated through improvements in mitochondrial function, metabolic regulation, and stress resilience.
Muscle health and physical performance
Studies suggest MOTS-C may support skeletal muscle function and metabolic efficiency — effects of particular relevance for aging patients experiencing sarcopenia or reduced physical capacity.
Stress resilience
MOTS-C appears to enhance cellular resilience to metabolic and oxidative stress — a key factor in the biology of aging and age-related disease.
Anti-inflammatory effects
Research suggests MOTS-C modulates inflammatory pathways, potentially contributing to the reduction of chronic low-grade inflammation — a primary driver of accelerated aging and metabolic disease.
How Is MOTS-C Typically Used?
MOTS-C is a research peptide administered via subcutaneous injection — self-administered by the user using a small insulin-type syringe, similar to other injectable peptide therapies.
The injection is typically given subcutaneously in the abdominal area. The process involves a very fine needle and is described by most users as minimally uncomfortable.
Typical research protocols involve daily or several-times-per-week injections over a defined period. Some protocols time injections around physical activity to potentially enhance the exercise-related metabolic effects suggested by the research.
As with all peptide therapies, appropriate medical guidance, precise dosing, and sourcing from reputable compounding facilities are essential considerations. The potency of MOTS-C's metabolic effects means that medical supervision is particularly important for patients with existing metabolic conditions.
What Makes MOTS-C Unique Among Longevity Peptides?
Several characteristics distinguish MOTS-C from other peptides in the longevity and metabolic medicine space:
Mitochondrial origin — MOTS-C is one of the very few peptides encoded by the mitochondrial genome rather than nuclear DNA, making it a direct product of and signal from the cell's energy-producing machinery.
Systemic metabolic regulation — unlike peptides that act primarily on specific tissues or receptor systems, MOTS-C appears to function as a systemic metabolic regulator, influencing energy metabolism across multiple organ systems.
Exercise biology connection — the overlap between MOTS-C's mechanisms and those of exercise places it at a unique intersection of metabolic medicine, physical performance, and longevity science.
Declining levels with age — the natural age-related decline in MOTS-C levels provides a compelling biological rationale for its investigation as a longevity intervention.
Who Is MOTS-C of Interest To?
Based on the current research landscape, MOTS-C has attracted interest among:
- Patients experiencing age-related metabolic decline, insulin resistance, or reduced energy levels
- Individuals interested in mitochondrial health as a foundation of longevity medicine
- Those pursuing comprehensive metabolic optimization as part of an anti-aging protocol
- Patients with metabolic syndrome or early type 2 diabetes seeking complementary approaches
- Athletes and physically active individuals interested in metabolic efficiency and performance
- Those exploring the intersection of exercise biology and longevity science
Important Considerations
MOTS-C is a research peptide and is not currently approved by the FDA or equivalent regulatory bodies as a pharmaceutical treatment for any specific condition. The evidence base, while scientifically compelling, is primarily derived from preclinical studies, with human clinical data still in early stages.
As with all research peptides, quality, sourcing, and medical guidance are essential. The metabolic potency of MOTS-C means that appropriate candidate evaluation and monitoring are particularly important.
Want to Learn More About Mitochondrial Peptide Therapy?
If you are curious about how MOTS-C or other mitochondrial and metabolic peptides might fit into a personalized longevity or metabolic optimization protocol, Dr. Alan Inman at Rejuvilife is available to discuss the current science and help you understand whether this approach may be relevant to your specific health goals.
Schedule a consultation at Rejuvilife and Dr. Inman will walk you through everything in detail — a thorough, personalized medical conversation tailored to your biology and objectives.
📱 WhatsApp: +506 8906-5454
📧 Email: rejuvilife.info@gmail.com
📍 Centro Médico Duo Medical, Escazú, San José, Costa Rica
Rejuvilife — Regenerative & Anti-Aging Medicine in Costa Rica | 5.0 ★ on Google